- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 164.64M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.75B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.12B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $831.3M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $801.6M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.11B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.5B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.38B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.39B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.73B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $6.73B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 168.5M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $31.9M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $15.3M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $90M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.21B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $3.14B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.62 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.64 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $142.7M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $16.3M |
| Net Income | Q1 2025 · Mar 31, 2024 | $105.1M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $131.9M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $290.9M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $441.2M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $732.1M |